Article
CYP3A7*1C polymorphism, serum dehydroepiandrosterone sulfate level, and bone mineral density in postmenopausal women.
Calcified tissue international - 1 Mar 2007
Bácsi K, Kósa J P, Borgulya G, Balla B, Lazáry A, Nagy Z, Horváth C, Speer G, Lakatos P
Abstract excerpt
The CYP3A7 enzyme metabolizes some steroid hormones, including dehydroepiandrosterone sulfate (DHEAS). The age-related decline of serum DHEAS levels is believed to contribute to osteoporosis. Previously, the CYP3A7*1C polymorphism has been shown to cause a persistent high CYP3A7 enzyme activity, resulting in lower levels of DHEAS in men. We hypothesized that the CYP3A7*1C polymorphism might contribute to bone...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
